Journal of Global Infectious DiseasesOfficial Publishing of INDUSEM and OPUS 12 Foundation, Inc. Users online:1016  
Print this pageEmail this pageSmall font sizeDefault font sizeIncrease font size     
Home About us Editors Ahead of Print Current Issue Archives Search Instructions Subscribe Advertise Login 
 


 
   Table of Contents     
ORIGINAL ARTICLE  
Year : 2020  |  Volume : 12  |  Issue : 4  |  Page : 191-196
A clinicohistopathological correlation of Hansen's disease in a rural tertiary care hospital of Central India


Department of Pathology Mahatma Gandhi Institute of Medical Sciences, Wardha, Maharashtra, India

Click here for correspondence address and email

Date of Submission05-Apr-2020
Date of Acceptance11-Jun-2020
Date of Web Publication30-Nov-2020
 

   Abstract 

Background: Leprosy is an ancient, chronic granulomatous infectious disease caused by Mycobacterium leprae, principally affecting the skin and peripheral nerves. The clinical manifestations of leprosy are variable and can mimic a variety of other skin diseases. Thus, histopathological examination plays an important role in early diagnosis and management. Aim: The aim was to study the clinicohistopathological correlation of all suspected cases of Hansen's disease. Materials and Methods: A retrospective study was conducted on 207 skin biopsies obtained from patients clinically diagnosed as new lesion of leprosy in the department of pathology from 2016 to 2019. Demographic, clinical details of the patients were retrieved from hospital information system. Hematoxylin–eosin- and Fite–Faraco-stained sections were evaluated for features confirming leprosy and further categorized as per Ridley–Jopling system. Sensitivity, specificity, and concordance rates were studied. Results: The male-to-female ratio was 1.5:1. The agreement between histopathological and clinical diagnoses was more than 90% in all the subclasses except for borderline tuberculoid leprosy (BT) and tuberculoid leprosy (TT) which showed an agreement of 86.5% and 88.4%, respectively. The sensitivity of clinical diagnosis ranged from 69.70% for indeterminate to 100% for histoid and neuritic types. The specificity ranged from 90% for BT and TT to 100% for neuritic leprosy. Conclusion: Clinical diagnosis of early leprosy lesions offers difficulties even to experienced dermatologists as a patient presents in different clinicopathological forms, depending on host immune status. Thus, the correlation between clinical, histopathological, and bacteriological features is required for diagnosis and classification of leprosy. Nerve damage is irreversible; therefore, early detection and treatment is important to prevent Grade 2 disabilities.

Keywords: Clinicohistopathological correlation, leprosy, morbidity

How to cite this article:
Atram MA, Ghongade PV, Gangane NM. A clinicohistopathological correlation of Hansen's disease in a rural tertiary care hospital of Central India. J Global Infect Dis 2020;12:191-6

How to cite this URL:
Atram MA, Ghongade PV, Gangane NM. A clinicohistopathological correlation of Hansen's disease in a rural tertiary care hospital of Central India. J Global Infect Dis [serial online] 2020 [cited 2021 Feb 28];12:191-6. Available from: https://www.jgid.org/text.asp?2020/12/4/191/302018



   Introduction Top


Leprosy is a chronic granulomatous infectious disease caused by noncultivable Mycobacterium leprae.[1] Although there has been a significant reduction in the prevalence of Hansen's disease (HD) worldwide since the mid-1980 to the elimination levels, new cases continue to arise in several Southeast Asian countries, particularly India and Indonesia, indicating continuous transmission.[2],[3]

Due to its clinical diversity and ability to mimic other skin diseases, it is difficult to diagnose leprosy clinically in early stages.[4] Thus, histopathological examination of skin biopsies plays a pivotal role in early diagnosis, categorization, and treatment to prevent permanent nerve damage and Grade 2 deformities.


   Materials and Methods Top


This study is a retrospective study carried out in the Department of Pathology of a tertiary care rural hospital. The study was approved by the institutional ethical committee. Skin biopsies from patients clinically diagnosed as new lesion of leprosy from 2016 to 2019 were included. Demographic, clinical details, histopathology, and treatment reports were retrieved from patient records in hospital information system and pathology records. Clinical details such as age, sex, site, type of lesion, and deformity were noted. A Ridley–Jopling criterion was used to classify the disease clinically and histopathologically.

Hematoxylin and Eosin- and modified Fite–Faraco (FF)-stained slides were examined by two investigators for changes in the epidermis, dermis, presence of granulomas, lymphohistiocytic infiltrate, epithelioid cells, Langhans giant cells, nerve involvement, and presence of acid-fast bacilli (AFB). Cases classified as indeterminate, histoid, and neuritic leprosy were also included in the study. Clinicohistopathological correlation was done for all cases. Slit-skin smear (SSS) findings were also reviewed, whenever possible.


   Results Top


Two hundred and seven skin biopsies diagnosed clinically as leprosy were included in this study. Of these, 189 cases were confirmed on histopathology as leprosy and 18 were negative. Of the 189 cases, 113 (59.78%) were male and 76 (42.21%) were female, with a ratio of 1.5:1. The youngest patient was 12 years old and the oldest was 84 years old. Majority of the cases were found in the age group of 21–40 years. Eleven cases had a positive family/contact history in neighborhood, and most of them were children.

The most common clinical presentation was hypoanesthetic patches found in 153 (80.95%). Nine patients (4.34%) had limb deformities, and 7 (1.5%) of them had tropical ulcer, whereas five patients came to the outpatient department for sudden-onset fever, erythematous eruptive lesion, and arthralgia.

The most common site of lesion was upper limb (107), followed by lower limb, trunk, and face. Clinically, borderline leprosy cases were in the largest number, together constituted nearly 50% of the cases (borderline tuberculoid leprosy [BT] – 64 and borderline lepromatous leprosy [BL] – 27), and followed by tuberculoid leprosy (TT) and indeterminate leprosy (IL). The distribution of cases in individual categories based on clinical and histopathological criteria is summarized in [Table 1].
Table 1: Histopathological diagnosis of clinically classified cases in individual categories

Click here to view


Clinical and histopathological findings

The patients of TT were diagnosed clinically by the presence of <5 asymmetrical, hypopigmented, hypoanesthetic patches. Microscopically, the dermis showed well-defined granulomas and lymphocytic infiltrate seen in 24/29 cases [Figure 1]a and b].
Figure 1: (a) Photomicrograph shows well developed epithelioid granuloma eroding the epidermis in tuberculoid leprosy (H and E, ×10). (b) Photomicrograph of tuberculoid leprosy shows classic tuberculoid granulomas comprised of epithelioid cells and giant cells surrounded by lymphocytes (H and E, ×40)

Click here to view


BT cases differed clinically from TT by a greater number of elevated lesions with altered sensation. Histopathological examination showed granulomas along superficial vascular plexus with variable number of Langhans giant cells. The bacillary index (BI) was 1 in 21 and 2 in 4 cases.

Clinically, mid borderline leprosy (BB) cases were diagnosed by the presence of irregularly dispersed ill-defined hypopigmented plaques and multiple nerve involvement. Histopathological hallmark of BB was the absence of Langhans giant cells and few lymphocytes and activated macrophages with prominent dermal edema. BI was three in most of the BB cases.

Cases with multiple asymmetrical nodular lesions and those with symmetrical shiny nodular lesions were categorized into BL and lepromatous leprosy (LL), respectively. Microscopically, BL cases showed dense lymphocytic infiltrates and foamy macrophages, whereas LL cases showed the presence of Grenz zone and Virchow cells [Figure 2]a and [Figure 2]b. The BI index was 5 in 12 of LL.
Figure 2: (a and b) Photomicrograph of lepromatous leprosy shows atrophic epidermis, grenz zone, and diffuse macrophage infiltration (H and E, ×10 and × 40)

Click here to view


Five of the seven cases were confirmed as histoid leprosy (HL) showed proliferation of spindle-shaped histiocytes oriented in storiform pattern with BI of six in all five cases [Figure 3]a, b1 and b2]. IL on histopathology revealed mild lymphohistiocytic infiltration around dermal appendages and nerves. No epithelioid granuloma was seen.
Figure 3: (a)Photomicrograph of histoid leprosy shows sheets of spindled shape histiocytes (H and E, ×10). (b1 and b2) Fite–Faraco stain reveals acid fast bacilli in classical sheaves of wheat arrangement (b1 ×10 and b2 ×40)

Click here to view


Three patients with pure neuritic leprosy had multiple nerve involvement in both limbs without skin lesions. Biopsies showed the presence of foamy histiocytes and lepra bacilli within the substance of nerve [Figure 4]. The histomorphological findings are shown in [Table 2].
Figure 4: Photomicrograph of nerve abscess (H and E, ×10) showing infiltration of nerve by inflammatory cells

Click here to view
Table 2: Histopathological findings observed in the epidermis and dermis along with bacillary index in leprosy cases

Click here to view


Clinical evidence of lepra reaction was found in five patients. Three patients had type I and two had type II reaction. All three patients of type I lepra reaction were in the age group of 20–40 years and from BT spectrum. Sections showed edema and fibrinoid necrosis within granulomas in the lower epidermis. Patients on multidrug treatment (MDT) with type II reaction were admitted to the emergency department with fever, tender eruptive lesions, and arthralgia. Multiple skin biopsies showed neutrophilic abscesses, vasculitis, and macrophages with fragmented bacilli.


   Discussion Top


Leprosy is an ancient disease of mankind that affects mainly peripheral nerves and skin but also affects other sites such as reticuloendothelial system, eyes, bone, joints, muscles, testes, and adrenals. It has varied clinical manifestations, which are associated with host immune responses.[1],[4],[5]

Leprosy can occur at all age groups.[6] In the present study, majority of the patients were in the age group of 21–40 years (51.1%), similar to a study conducted by Kumar et al. (62%).[7] Leprosy has a variable and long incubation period which is responsible for this age distribution.[6]

Leprosy is common in males, with a male-to-female ratio of 1.5:1 in this study. Male preponderance might be attributed to increased chances of exposure due to increased job-related mobility.[8] Social customs and taboos may also account for the smaller number of females reporting to the hospital. Male preponderance of leprosy was seen in a study by Semwal et al.[9]

A hypoanesthetic patch was the most common clinical presentation in our study.[6] Since skin and nerves are the most common sites of M. leprae infection, signs and symptoms related to the skin and nerves were common.[6]

Of the 207 patients diagnosed clinically as leprosy, biopsies showed evidence of leprosy in 189 cases with overall agreement 92.4% in the present study. Ridley and Jopling[10] found agreement between clinical and histological types in 68.3%, similarly Kini and Choudhary, 92.4%;[4] Mathur et al., 80.4%;[11] Sharma and Rai, 85.8%;[12] and Murunantham et al., 62.85%.[13]

The BT and BL comprised majority of the cases, followed by polar type. Our findings show a similar dominance of cases in the borderline group, as noted by Bijjaragi et al.[14]

In the present study, the most common clinical and histological subtype was BT, followed by TT similar to various studies in the literature.[4],[6],[15]

In our study, the highest clinicohistopathological agreement was noted for LL (97.1%). It was on the higher side in our study as the histopathological diagnosis of LL is rather more straightforward than other categories owing to being polar form. The least agreement was noted for BT (86.5%) and TT (88.4%). As some of the cases diagnosed clinically, TT was categorized histopathologically into BT and vice versa. This shift of one group is understandable as clinical and histopathological features of TT and BT were overlapping. However, it is important to categorize TT and BT histopathologically as it alerts the treating clinician to the possibility of a type 1 reaction that is common patients of BT on treatment.[15],[16] We observed minor discrepancy (shift of one group on polar tuberculoid side) in four cases (4 – TT) and major discrepancy in nine cases (5 – BL and 4 – IL). The clinicohistopathological agreement in each category is summarized in [Table 3].
Table 3: Sensitivity, specificity, positive predictive value, negative predictive value, and agreement of clinical diagnosis for individual categories

Click here to view


IL is an early and transitory stage of leprosy seen in persons whose immunological status is yet to be determined. It has nonspecific histology, so it becomes difficult to diagnose.[6] The definitive diagnosis of IL depends on demonstration of nerve lesions and AFB, but can diagnosed even without finding a single bacillus, if clinical and histopathological features are suggestive, especially in endemic areas.[6] We found IL more on histopathology (33 cases) than clinically (23) similar to Kini and Chaudhary[4] [Table 4].
Table 4: Comparison of concordance rates for tuberculoid leprosy, borderline tuberculoid leprosy, borderline leprosy, borderline lepromatous leprosy, lepromatous leprosy, and indeterminate leprosy in our study with other studies

Click here to view


HL is bacillary-rich leproma composed of spindle-shaped histiocytes with fibromatoid tendency in chronic form.[17] Its incidence is estimated to be 2.79%–3.60% in India.[18] In the present study, it constitutes around 2.64% of all leprosy cases. HL was described in patients on inadequate dapsone therapy; however, occasional cases of HL can occur de novo.[17]

In our study, three patients presented with primary neuritic leprosy without cutaneous lesion. In Indian studies, pure neuritic leprosy constitutes about 4%–18% of leprosy patients.[19] In study by Jacob M and Arunthathi S[20], 67% of primary neuritic leprosy patients developed skin lesions on long-term follow-up. This suggests that neuritic symptoms probably are the earliest symptoms of leprosy before the development of skin lesions, so patients of pure neuritic leprosy must be followed up for long term.[20] Clinicopathological agreement of neuritic leprosy was 100% in our study similar to Kini and Choudhary.[4]

Histopathological examination with FF stain of 189 cases showed the presence of lepra bacilli in 98 (51.85%), whereas no bacilli in 91 (48.14%) cases. All 100% cases of TT showed no lepra bacilli, whereas mid-borderline, BL, LL, and HL showed the presence of bacilli in 100% of cases. Our findings were similar to a study conducted by Bhushan et al.[21]

The results of SSS correlated with FF-stained sections in LL spectrum. Although SSS test has high sensitivity and helps in establishing an early diagnosis, it has low specificity as 70% of the cases are smear negative.[9] Furthermore, BI in granulomas was found to be higher on FF than that of SSS by Ridley and Jopling who opined that SSS reflected density at particular foci while sections took into account the size of the lesion along with density.[9],[10]

Lepra reactions are an important cause of morbidity in leprosy patients. Erythema nodosum leprosum (ENL) (type II reaction) is an immunological complication affecting approximately 50% of the patients with LL and 10% of BB.[22] In the present study, two patients of LL presented with ENL after successful completion of MDT. Awareness of the diverse clinical features of ENL is useful for the accurate diagnosis successful management and prevention of permanent disabilities.[22]

The reasons for emergence of new cases in post elimination era, is the long incubation period of leprosy which range from few weeks to 30 years. Thus, the cases appear “hidden” and the numbers cannot go up or down suddenly.[23] Furthermore, social stigma prevents most patients from seeking medical treatment until it is too late.[6]

Nerve damage is irreversible, and once disabilities set in, social rehabilitation becomes very challenging. Although the global disability rate reduced from 4.5% to 3.8%,[2] in India, the percentage of Grade 2 disability (G2D) among new cases detected has increased from 3.10% by 2010–2011 to 4.61% in 2014–2015. The high G2D rate among new cases indicates that leprosy is being detected late, and there may be hidden cases in the community.[24] Therefore, early detection and treatment of HD is important.

Clinical diagnosis of early leprosy lesions is often difficult even to experienced dermatologists because of the varied clinical manifestations. Thus, we emphasized the importance of histopathological examination in all clinically suspected cases of HD for early diagnosis and treatment before any disability sets in.


   Conclusion Top


There is significant reduction in prevalence rate of leprosy to 0.23 / 10,000 population worldwide in 2020. Despite this India had more than 50% of leprosy patients of the world, which necessities identifying the reasons for transmission and to adopt preventive measures to control the disease. A leprosy patient presents in different clinicopathological forms, depending on the host immune status. Borderline cases represent majority of the lesions of leprosy and must receive special attention due to their unstable immunological status. Since the impact of finding one new case of leprosy is huge, histopathological examination of skin biopsy is recommended in all clinically suspected cases of leprosy for accurate diagnosis and treatment and to prevent nerve damage and permanent disabilities.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

 
   References Top

1.
Nath I, Saini C, Valluri VL. Immunology of leprosy and diagnostic challenges. Clin Dermatol 2015;33:90-8.  Back to cited text no. 1
    
2.
Rao PN, Suneetha S. Current Situation of Leprosy in India and its Future Implications. Indian Dermatol Online J. 2018;9 (2):83-89.  Back to cited text no. 2
    
3.
Global leprosy update, 2018: Moving towards a leprosy free world (WER Nos. 35/36,2019;94:389-412.  Back to cited text no. 3
    
4.
Kini RG, Choudhary H. Clinicopathological correlation in diagnosis of Hansen's disease: A histopathologist's perspective. J Interdiscipl Histopathol 2017;5:48-54.  Back to cited text no. 4
    
5.
Eidt LM. Brief history of leprosy: Its expansion from the world to the Americas, Brazil and Rio Grande do Sul and its trajectory in Brazilian public health. Health Soc 2004;13:76-88.  Back to cited text no. 5
    
6.
Suri SK, Iyer RR, Patel DU, Bandil S, Baxi S. Histopathology and cinico- histopathological correlation in of Hansen's disease. J Res Med Dent Sci 2014;2:37-44.  Back to cited text no. 6
    
7.
Kumar A, Negi SR, Vaishnav K. A study of clinico-histopathological correlation of leprosy in a tertiary care hospital in western district of Rajasthan. J Res Med Dent Sci 2014;2 (3):43-8  Back to cited text no. 7
    
8.
Adhikari RC, Sayami G. Clinicohistopathological correlation of skin biopsies in leprosy. J Pathol Nepal 2013;3:452-8.  Back to cited text no. 8
    
9.
Semwal S, Joshi D, Goel G, Asati D, Kapoor N. Clinico-histological correlation in Hansen's disease: Three-year experience at a newly established tertiary care center in central India. Indian J Dermatol 2018;63:465-8.  Back to cited text no. 9
[PUBMED]  [Full text]  
10.
Ridley DS, Jopling WH. A classification of leprosy for research purposes. Lepr Rev 1962;33:119-28.  Back to cited text no. 10
    
11.
Mathur MC, Ghimire RB, Shrestha P, Kedia SK. Clinicohistopathologica correlation in leprosy. Kathmandu Univer Med J 2011;36:248-51.  Back to cited text no. 11
    
12.
Sharma S, Rai NN. Demographic profile and clinicopathologic concordance of leprosy in North-West part of Rajasthan, India: A 2 year's prospective study. Int J Clinicopathol Correl 2018;2:1-5.  Back to cited text no. 12
  [Full text]  
13.
Murugnantham A, Munniswamy V, Sivaraman J. Clinical and histopathological features of Hansen's disease. Ann Pathol Lab Med 2017;4:454-459  Back to cited text no. 13
    
14.
Bijjaragi S, Kulkarni V, Suresh KK, Kumar P. Correlation of clinical and histopathological classification of leprosy in post elimination era. Indian J Lepr 2012;84:271-5.  Back to cited text no. 14
    
15.
Rizvi AA, Sharma YK, Dash K, Tyagi N, Yadava R, Sadana D. An epidemiological and clinicohistopathological study of leprosy in semi-urban area under Pimpri Chinchwad Municipal Corporation in Pune district of Maharashtra. Med J DY Patil Univer 2015;8:609-13.  Back to cited text no. 15
    
16.
Parakh R, Mulchandani V, Parakh KK. Clinico-histopathological correlation in leprosy – A tertiary care hospital based study at Udaipur. Int J Sci Res 2015;4:56-8.  Back to cited text no. 16
    
17.
Punia RP, Dhingra H, Baliyan A, Handa U, Mohan H, Thami GP. Clinicopathologic spectrum of Histoid leprosy. Int J Curr Res 2017;9:50765-9.  Back to cited text no. 17
    
18.
Gupta SK. Histoid leprosy: Review of the literature. Int J Dermatol 2015;54:1283-8.  Back to cited text no. 18
    
19.
Rao PN, Suneetha S. Pure neuritic leprosy: Current status and relevance. Indian J Dermatol Venereol Leprol 2016;82:252-61.  Back to cited text no. 19
[PUBMED]  [Full text]  
20.
Jacob M, Arunthathi S. The Wague. A study primary neuritic leprosy (Abst): In Proc XIII Int Lep Congr. (September 11-17) 1988:313.  Back to cited text no. 20
    
21.
Bhushan P, Sardana K, Koranne RV, Choudhary M, Manjul P. Diagnosing multibacillary leprosy: A comparative evaluation of diagnostic accuracy of slitskin smear, bacterial index of granulomas and WHO operational classification. Indian J Dermatol Venereol Leprol 2008;74:322-6.  Back to cited text no. 21
[PUBMED]  [Full text]  
22.
Negera E, Walker SL, Girma S, Doni SN, Tsegaye D, Lambert SM, et al. Clinico-pathological features of erythema nodosum leprosum: A case-control study at ALERT hospital, Ethiopia. PLoS Negl Trop Dis 2017;11:e0006011.  Back to cited text no. 22
    
23.
Sengupta U. Elimination of leprosy in India: An analysis. Indian J Dermatol Venereol Leprol 2018;84:131-6.  Back to cited text no. 23
[PUBMED]  [Full text]  
24.
Guidelines for Sparsh Leprosy Awareness Campaign, NLEP, Government of India New Delhi.[Last accessed on 2020 April 02] http://nlep.nic.in/pdf/GuidelinesforSparshLeprosyawarenessCamaign.pdf.  Back to cited text no. 24
    

Top
Correspondence Address:
Dr. Pravinkumar V Ghongade
Department of Pathology, Mahatma Gandhi Institute of Medical Sciences, Sewagram, Wardha - 442 102, Maharashtra
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/jgid.jgid_58_20

Rights and Permissions


    Figures

  [Figure 1], [Figure 2], [Figure 3], [Figure 4]
 
 
    Tables

  [Table 1], [Table 2], [Table 3], [Table 4]



 

Top
  
 
  Search
 
  
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Email Alert *
    Add to My List *
* Registration required (free)  


    Abstract
   Introduction
    Materials and Me...
   Results
   Discussion
   Conclusion
    References
    Article Figures
    Article Tables

 Article Access Statistics
    Viewed1060    
    Printed36    
    Emailed0    
    PDF Downloaded7    
    Comments [Add]    

Recommend this journal

Sitemap | What's New | Feedback | Copyright and Disclaimer | Contact Us
2008 Journal of Global Infectious Diseases | Published by Wolters Kluwer - Medknow
Online since 10th December, 2008